Robert Langer, 10% Owner at INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV), sold 7,500 shares at $3.37 ($28K) on 2013-06-03, disclosed to the SEC on 2013-06-05.
Scheduled sale ($28k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.37 | 2,500 | $8K | 30.1% |
| 2 | $3.90 | 2,500 | $10K | 34.9% |
| 3 | $3.91 | 2,500 | $10K | 35.0% |
| Total | $3.73 avg | 7,500 | $28K | 100% |
| Filing → |
| RUBY | SELL | 2019-04-17 | $132K | — | Filing → |
| RUBY | SELL | 2019-01-18 | $109K | — | Filing → |
| NVIV | SELL | 2013-05-31 | $25K | — | Filing → |